Prescribers and Pharmaceutical Representatives: Why Are We Still Meeting?
Fischer, Melissa A
Keough, Mary Ellen
Baril, Joann L
Mazor, Kathleen M
Von Worley, Ann
Gurwitz, Jerry H
Journal of general internal medicine 2009 Jul; 24(7): 795-801
Research suggests that pharmaceutical marketing influences prescribing and may cause cognitive dissonance for prescribers. This work has primarily been with physicians and physician-trainees. Questions remain regarding why prescribers continue to meet with pharmaceutical representatives (PRs).
Showing items related by title, author, creator and subject.
Ladd, Elissa C; Mahoney, Diane Feeney; Emani, Srinivas (2010-12-01)To assess nurse practitioners' interactions with pharmaceutical industry promotional activities and their perception of information reliability and self-reported prescribing behaviors.
Mazor, Kathleen M.; Simon, Steven R.; Gurwitz, Jerry H. (2004-08-09)BACKGROUND: Ethical and professional guidelines recommend disclosure of medical errors to patients. The objective of this study was to review the empirical literature on disclosure of medical errors with respect to (1) the ...